Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Kansas City Heart Rhythm Research Foundation
- Study ID
- NCT06061757
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Imaging guidance with TEE and ICE for Left atrial appendage closure — DEVICEThe occluder size for both LAAC devices will be selected based on the maximal diameter of the LAA orifice following the manufacturer guidelines and using the maximal length of the LAA measured on Echocardiogram. Intraprocedural measurements of the LAA width and depth were acquired on both ICE and TEE per protocol. Both ICE and TEE will be used to assess for any procedural complications prior to insertion of the device delivery sheath.
Study Details
This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural guidance similar to Transesophageal echocardiography (TEE) (GE 6VT-D ULTRASOUND TRANSDUCER) for Left atrial appendage closure (LAAC). The study will enroll approximately 52 subjects and will be followed through 12 months.
Key Dates
- Start date
- May 10, 2023
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm 1 - TEE Primary imaging guidanceTEE is the primary imaging guidance with 4D ICE is the secondary
- Experimental: Arm 2 - ICE Primary Imaging Guidance4D ICE is the primary imaging guidance and TEE is the secondary
Primary Outcome Measure
Success of Implantation of Left Atrial Appendage Closure (LAAC) device [ Time Frame: 1 Day ]
Central Contacts
- Donita Atkins816-651-1969
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kansas City Heart Rhythm Institute - Roe Clinic | Overland Park | Kansas | 66211 | Dhanunjaya Lakkireddy, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Overland Park, KS
By condition
By specialty
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- User-friendliness of a Portable Driving SimulatorRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2/PHASE3 · Recruiting · DiaMedica Therapeutics Inc · Fairhope, Alabama